1.
Sox18 induces development of the lymphatic vasculature in mice
by Karnezis, Tara
Nature, 2008-12-04, Vol.456 (7222), p.643-647

2.
Stress and Cardiovascular Disease: An Update on Current Knowledge
by STEPTOE, Andrew
Annual review of public health, 2013, Vol.34 (1), p.337-354

3.
Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health
by MORISSEAU, Christophe
Annual review of pharmacology and toxicology, 2013, Vol.53 (1), p.37-58

4.
Biophysical Characterization of the Underappreciated and Important Relationship Between Heart Rate Variability and Heart Rate
by Monfredi, Oliver
Hypertension (Dallas, Tex. 1979), 2014-12, Vol.64 (6), p.1334-1343

5.
Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction
by Madhur, Meena S
Hypertension (Dallas, Tex. 1979), 2010-02, Vol.55 (2, Part 2 Suppl), p.500-507

6.
Inflammation, Immunity, and Hypertension
by Harrison, David G
Hypertension (Dallas, Tex. 1979), 2011-02, Vol.57 (2), p.132-140

7.
Arterial Stiffening Precedes Systolic Hypertension in Diet-Induced Obesity
by WEISBROD, Robert M
Hypertension (Dallas, Tex. 1979), 2013, Vol.62 (6), p.1105-1110

8.
Angiotensin-(1―7)
by SANTOS, Robson Augusto
Hypertension (Dallas, Tex. 1979), 2014, Vol.63 (6), p.1138-1147

9.
Circulating Angiotensin II Gains Access to the Hypothalamus and Brain Stem During Hypertension via Breakdown of the Blood–Brain Barrier
by Biancardi, Vinicia Campana
Hypertension (Dallas, Tex. 1979), 2014-03, Vol.63 (3), p.572-579

10.
Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor–Dependent Mechanism
by Deshotels, Matthew R
Hypertension (Dallas, Tex. 1979), 2014-12, Vol.64 (6), p.1368-1375

11.
Hypertension Induces Brain β-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vascul...
by Carnevale, Daniela
Hypertension (Dallas, Tex. 1979), 2012-07, Vol.60 (1), p.188-197

12.
Dairy Consumption and Incidence of Hypertension : A Dose-Response Meta-Analysis of Prospective Cohort Studies
by Soedamah-Muthu, S.S
Hypertension (Dallas, Tex. 1979), 2012, Vol.60 (5), p.1131-1137

13.
The Carotid Body as a Therapeutic Target for the Treatment of Sympathetically Mediated Diseases
by Paton, Julian F.R
Hypertension (Dallas, Tex. 1979), 2013-01, Vol.61 (1), p.5-13

14.
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice
by Panjwani, Naim
Endocrinology (Philadelphia), 2013-01, Vol.154 (1), p.127-139

15.
Enhanced Vasodilator Activity of Nitrite in Hypertension: Critical Role for Erythrocytic Xanthine Oxidoreductase and Translational Potential
by Ghosh, Suborno M
Hypertension (Dallas, Tex. 1979), 2013-05, Vol.61 (5), p.1091-1102

16.
Autonomic-Immune-Vascular Interaction: An Emerging Concept for Neurogenic Hypertension
by Zubcevic, Jasenka
Hypertension (Dallas, Tex. 1979), 2011-06, Vol.57 (6), p.1026-1033

17.
Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
by BADER, Michael
Annual review of pharmacology and toxicology, 2010, Vol.50 (1), p.439-465

18.
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
by DeFronzo, R. A
Diabetologia, 2010-04-02, Vol.53 (7), p.1270-1287

19.
Brain Microglial Cytokines in Neurogenic Hypertension
by Shi, Peng
Hypertension (Dallas, Tex. 1979), 2010-08, Vol.56 (2), p.297-303

20.
T Regulatory Lymphocytes Prevent Angiotensin II–Induced Hypertension and Vascular Injury
by Barhoumi, Tlili
Hypertension (Dallas, Tex. 1979), 2011-03, Vol.57 (3), p.469-476
